Scientists test Triple-Threat therapy for Tough-to-Treat head and neck cancer
NCT ID NCT07325539
Summary
This study is testing whether adding a special low-dose radiation to a standard chemotherapy and immunotherapy combination can better control advanced nasopharyngeal cancer that has returned or spread. It will involve about 55 adults with this specific type of head and neck cancer who have not yet received treatment for their recurrent or metastatic disease. The main goal is to see if this new approach can delay the cancer from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.